| 244.375 9.845 (4.2%) | 11-11 15:56 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 308.35 | 1-year : | 360.15 |
| Resists | First : | 263.99 | Second : | 308.35 |
| Pivot price | 210.34 |
|||
| Supports | First : | 213.85 | Second : | 182.86 |
| MAs | MA(5) : | 232.01 |
MA(20) : | 206.88 |
| MA(100) : | 216.34 |
MA(250) : | 232.76 |
|
| MACD | MACD : | 8.7 |
Signal : | 3.9 |
| %K %D | K(14,3) : | 63.3 |
D(3) : | 58 |
| RSI | RSI(14): 69.7 |
|||
| 52-week | High : | 349.76 | Low : | 178.25 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ UFPT ] has closed below upper band by 5.2%. Bollinger Bands are 176% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 234.93 - 235.8 | 235.8 - 236.5 |
| Low: | 223.96 - 225.04 | 225.04 - 225.91 |
| Close: | 232.86 - 234.58 | 234.58 - 235.95 |
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Sun, 09 Nov 2025
4,820 Shares in UFP Technologies, Inc. $UFPT Purchased by Fox Run Management L.L.C. - MarketBeat
Sat, 08 Nov 2025
Decoding UFP Technologies Inc (UFPT): A Strategic SWOT Insight - GuruFocus
Fri, 07 Nov 2025
UFP TECHNOLOGIES INC SEC 10-Q Report - TradingView
Thu, 06 Nov 2025
UFP Technologies, Inc. $UFPT Shares Purchased by EFG Asset Management North America Corp. - MarketBeat
Wed, 05 Nov 2025
UFP Technologies, Inc. (NASDAQ:UFPT) Q3 2025 Earnings Call Transcript - Insider Monkey
Tue, 04 Nov 2025
UFP Technologies Inc (UFPT) Q3 2025 Earnings Call Highlights: St - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 8 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 3.6 (%) |
| Held by Institutions | 120 (%) |
| Shares Short | 1,170 (K) |
| Shares Short P.Month | 1,330 (K) |
| EPS | 8.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 49.99 |
| Profit Margin | 11.3 % |
| Operating Margin | 16.4 % |
| Return on Assets (ttm) | 11.5 % |
| Return on Equity (ttm) | 19.2 % |
| Qtrly Rev. Growth | 37.2 % |
| Gross Profit (p.s.) | 21.95 |
| Sales Per Share | 76.33 |
| EBITDA (p.s.) | 14.99 |
| Qtrly Earnings Growth | 26.2 % |
| Operating Cash Flow | 83 (M) |
| Levered Free Cash Flow | 41 (M) |
| PE Ratio | 28.09 |
| PEG Ratio | 0 |
| Price to Book value | 4.84 |
| Price to Sales | 3.17 |
| Price to Cash Flow | 22.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|